Carrie Eglinton Manner is the President and Chief Executive Officer of OraSure Technologies Inc., a leading provider of point-of-care and home diagnostic tests. With a robust background in the life sciences industry, Manner has held several key leadership positions that have prepared her for her current role. Prior to joining OraSure, she served as the Executive Vice President and Chief Operating Officer at Myriad Genetics, where she was instrumental in driving the company's growth and operational excellence. Her career also includes significant stints at companies like Johnson & Johnson and Boston Scientific, where she honed her skills in strategic planning and business development. As the CEO of OraSure Technologies, Manner has been pivotal in steering the company towards new heights of innovation and market expansion. Under her leadership, OraSure has successfully expanded its portfolio of diagnostic solutions, particularly in the areas of infectious diseases and substance abuse. Manner's strategic vision has been crucial in navigating the complexities of the healthcare industry, ensuring that OraSure remains at the forefront of technological advancements. Her commitment to enhancing global health outcomes is evident in the company's ongoing efforts to develop accessible and reliable diagnostic tools. Manner's achievements extend beyond her corporate roles; she is also recognized for her contributions to the broader industry. She has been an active participant in various professional organizations and advisory boards, advocating for advancements in healthcare and diagnostics. Her leadership style, characterized by a focus on collaboration and innovation, has earned her respect and admiration within the industry. As OraSure continues to grow under her guidance, Manner remains dedicated to improving patient care through cutting-edge diagnostic solutions.